Chanda Yonzon
About Chanda Yonzon
Chanda Yonzon is a Senior Director at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in pharmaceutical product characterization and process analytical technology.
Current Position at Bristol Myers Squibb
Chanda Yonzon currently serves as the Senior Director at Bristol Myers Squibb in Summit, New Jersey, United States. In this role, Chanda leverages extensive experience in pharmaceutical product development and characterization to lead critical initiatives within the organization.
Previous Roles at Bristol Myers Squibb and Celgene
Before assuming the role of Senior Director, Chanda served as the Director at Bristol Myers Squibb from 2018 to 2022. Prior to Bristol Myers Squibb, Chanda held the position of Director of Analytical Development at Celgene from 2018 to 2019, where responsibilities included overseeing analytical methodologies and ensuring quality in pharmaceutical development.
Experience at Gilead Sciences
Chanda Yonzon has considerable experience from working at Gilead Sciences. Between 2017 and 2018, Chanda was a Senior Research Scientist. Before that, Chanda worked as Research Scientist II from 2014 to 2017. During these periods, Chanda contributed significantly to pharmaceutical research and development.
Tenure at Merck and Schering-Plough Research Institute
From 2006 to 2014, Chanda Yonzon worked at Merck and Schering-Plough Research Institute. Initially, Chanda held the position of Senior Scientist/Associate Principal Scientist at Schering-Plough from 2006 to 2009 and later transitioned to Merck, serving as Associate Principal Scientist from 2009 to 2014. Tasks included engaging in extensive pharmaceutical research and process improvement.
Educational Background in Chemistry
Chanda Yonzon has a robust educational foundation in Chemistry. Chanda earned a Ph.D. in Chemistry from Northwestern University, completing the program from 2001 to 2006. Additionally, Chanda received a Bachelor’s degree in Chemistry from Fairmont State University, completed between 1997 and 2001.
Expertise in Pharmaceutical Characterization and Process Analytical Technology
Chanda Yonzon is highly skilled in the characterization of pharmaceutical products using advanced spectroscopic techniques including infra-red, Raman, and terahertz spectroscopy. Chanda has implemented Process Analytical Technology (PAT) to improve manufacturing efficiency and product quality, demonstrating proficiency in both technical and applied aspects of pharmaceutical analysis.
Publications and Conference Presentations
Chanda Yonzon has an extensive publication record, with 25 journal articles to date. Additionally, Chanda has presented research findings at numerous scientific conferences, contributing to the broader field of pharmaceutical analysis and sharing expertise with the scientific community.